Current Assets
Short-Term Investments
Pfizer Short-Term Investments decreased by 8.7% to $11.37B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 28.4%, from $15.89B to $11.37B. Over 5 years (FY 2020 to FY 2025), Short-Term Investments shows an upward trend with a 3.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 5, 2026
How to read this metric
Higher levels indicate effective cash management and potential for interest income, whereas lower levels might suggest cash is being deployed into operations.
Detailed definition
These are marketable securities and financial instruments that are expected to be converted into cash within one year. T...
Peer comparison
Common among large-cap firms that manage treasury operations to optimize returns on idle cash.
Metric ID:
short_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.33B | $27.73B | $29.13B | $21.43B | $31.52B | $34.83B | $22.32B | $17.81B | $42.15B | $41.03B | $9.84B | $11.21B | $6.05B | $8.86B | $19.43B | $15.89B | $11.61B | $13.64B | $12.45B | $11.37B |
| QoQ Change | — | +43.5% | +5.0% | -26.4% | +47.1% | +10.5% | -35.9% | -20.2% | +136.7% | -2.7% | -76.0% | +13.9% | -46.0% | +46.5% | +119.3% | -18.3% | -26.9% | +17.5% | -8.7% | -8.7% |
| YoY Change | — | — | — | — | +63.1% | +25.6% | -23.4% | -16.9% | +33.7% | +17.8% | -55.9% | -37.0% | -85.7% | -78.4% | +97.6% | +41.7% | +92.0% | +54.0% | -35.9% | -28.4% |
Range$6.05B – $42.15B
CAGR-10.6%
Avg YoY Growth+4.0%
Median YoY Growth+0.5%
Current Streak2 quarters decline
Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Pfizer's short-term investments?
- Pfizer (PFE) reported short-term investments of $11.37B in Q1 2026.
- How has Pfizer's short-term investments changed year-over-year?
- Pfizer's short-term investments decreased by 28.4% year-over-year, from $15.89B to $11.37B.
- What is the long-term trend for Pfizer's short-term investments?
- Over 5 years (2020 to 2025), Pfizer's short-term investments has grown at a 3.6% compound annual growth rate (CAGR), from $10.44B to $12.45B.
- What does short-term investments mean?
- Financial investments that the company expects to turn into cash within one year.